Company Profile
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Latest News
GE HealthCare Technologies Inc. (GEHC) Beats Q2 Expectations, Reaffirms 2026 Outlook Despite CFO Transition
Fed Meeting, Inflation, Boeing, Meta, Apple, Exxon, and More to Watch This Week
Can GE HealthCare Sustain Growth in Q2 Amid Persistent Cost Headwinds?
| Sector | Healthcare |
| Industry | Medical Devices |
| Website | https://www.gehealthcare.com |
| Audit Risk | 1 |
| Board Risk | 5 |
| Overall Risk | 3 |
| Market Cap | 27.56B |
| Trailing P/E | 14.53 |
| Forward P/E | 11.3 |
| Dividend Rate | 0.14 |
| Dividend Yield | 0.23% |
| Trailing Annual Div. Rate | 0.14 |
| Trailing Annual Div. Yield | 0.23% |
| Trailing EPS | 4.17 |
| Forward EPS | 5.36 |
| Book Value | 23.45 |
| Price-to-Book | 2.58 |
| Enterprise-to-Revenue | 1.72 |
| Enterprise-to-EBITDA | 10.25 |
| Short Ratio | 3.52 |
| Ex-Dividend Date | 07/24/2026 |
| Dividend Date | 08/14/2026 |
| Earnings Date | 07/29/2026 |
| Earnings Call Date | 07/29/2026 |
| Earnings Average | 1.04 |
| Earnings Low | 1.01 |
| Earnings High | 1.07 |
| Revenue Average | 5.26B |
| Revenue Low | 5.18B |
| Revenue High | 5.30B |